The U.S. FDA Has Authorized 235 Different Coronavirus Tests

The U.S. FDA announced on September 1, 2020, that it has authorized 235 coronavirus diagnostic tests, which include 190 molecular tests, 41 antibody tests, and 4 antigen tests. The most frequently discussed tests are RT-PCR, the nasal-swab test that detects viral RNA, and antibody tests, that detect if you have an immune response due to past exposure to the SARS-CoV-2 coronavirus.

Previously, the U.S. CDC reported on August 28, 2020, the percentage of respiratory specimens testing positive for SARS-CoV-2 decreased from 6.2% during week #33 to 5.7% during week #34.